David Baram - CRISPR Interview - BIO CEO 2023

How IRA Would Disincentivize Rare Disease R&D - House Energy & Commerce Committee Hearing

BIO Policy Pulse: Phyllis Arthur Testifies on Need to Reauthorize PAHPA, Pass PASTEUR Act

BIO 2023 - Ted Love and Paul Hastings

BIO 2023 - Governor Maura Healey

BIO CEO Rachel King - Welcome to BIO 2023

BIO Policy Pulse: How PBMs Leave Patients Behind

Senate HELP Committee Hearing on PBMs and House W&M Health Subcommittee Hearing on Innovation

BIO2023 International Convention in Boston - Vlad Vitoc - Presentations

Antimicrobial Resistance Hearing-Oversight & Investigations Subcommittee-Energy & Commerce Committee

BIO Chief Policy Officer John Murphy Comments on Texas Judge's Ruling to Suspend mifepristone

Mexico Corn Ban and TRIPS Waiver Dominate Discussion in USTR Hearing

Treasury Secretary Janet Yellen Testifies about Banking Crisis -Senate Finance Committee Hearing

BIO Policy Pulse: Senate Hearing on Covid-19 Vaccine Pricing

Register Now to Secure Your Place at the Largest Biotechnology Event in the World – Boston, June 5-8

BIO's Policy Pulse: Nick Shipley - House Hearing on Intellectual Property and China

U.S. Senate Commerce Committee Legislative Hearing on the PBMs Transparency Act of 2023

The Food and Agriculture Climate Alliance Releases Farm Bill Policy Recommendations

David Baram - CRISPR Interview - BIO CEO 2023

Yaping Shou, Venture Partner at Lilly Asia Ventures, Discusses U.S.-China Biotech Trends-BIO CEO2023

Mexico’s Proposed Biotech Corn Ban Crops Up in Senate Farm Bill Hearing

Rachel King and Kelly Schulz - Maryland Tech Council Advocacy Summit, Annapolis, MD

Rachel King, BIO's Interim CEO, Maryland Tech Council Advocacy Summit in Annapolis, January 19, 2023

JPM Week 2023 - BIO Partnering

I am BIO Podcast Explained - Let’s Get Uncomfortable: Talking About Women’s Health